Should Insurance Cover Ozempic, Weight Loss Drugs?
- Weight loss drugs are the biggest disruptive technology I have ever seen.
- GLP-1 drugs Ozempic and Wegovy are popular for off-label use for weight loss on average of about 15% or more.
- GLP-1 is a hormone our bodies use the triggers the pancreas to produce insulin.
- These drugs are owned by Novo Nordisk.
- In America, 70% of people are obese or overweight.
- Obesity contributes to heart failure, breast cancer, colorectal cancer, prostate cancer, asthma, stroke, heart disease, Alzheimer's, chronic back pain, arthritis, diabetes, and hypertension.
- The direct and indirect costs of obesity total $1.7 trillion, or 7% of U.S. GDP.
- A 15% reduction in body weight would move 43 million Americans out of the obese column.
- Globally 800 million people, including 50 million children, are now obese.
- In July a bipartisan group of lawmakers reintroduced a bill to reauthorize Medicare coverage of weight-loss medications.
https://linktr.ee/RobBlack.
#short #shorts #shortvideo #shortsvideo #trending #stocks #stockmarket #stock #market #finance #investing #investment #latest #fed #interestrates